Gennex Laboratories board meets on May 30 for Q4FY26 results
Gennex Laboratories Limited will hold a board meeting on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The meeting will be held in Hyderabad, and the notice was published in major newspapers on May 20, 2026.

*this image is generated using AI for illustrative purposes only.
Gennex Laboratories Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the report of the statutory auditors.
The meeting is scheduled to take place at the corporate office of the company located at Akash Ganga, 04th Floor, Plot No.144, Srinagar Colony, Hyderabad – 500 073, Telangana State, India. The proceedings will be conducted in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has intimated the stock exchanges regarding the meeting. The notice was published in both Business Standard and Saksham (Local-Telugu) newspapers on May 20, 2026. The official notice is also available on the company's website and the BSE Limited website for shareholder reference.
| Meeting Details | Information |
|---|---|
| Date | May 30, 2026 |
| Day | Saturday |
| Time | Not specified |
| Location | Hyderabad, Telangana |
| Agenda | Audited Financial Results for Q4 and FY26 |
The adoption of the audited financial results for the full fiscal year and the fourth quarter is a key regulatory requirement. Shareholders and investors can access the detailed results once they are approved and officially filed following the board meeting.
Historical Stock Returns for Gennex Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +11.05% | +6.31% | -25.05% | -16.48% | +68.98% |
How did Gennex Laboratories' revenue and profitability trends for FY26 compare to the previous fiscal year, and what drove any significant changes?
Will Gennex Laboratories announce any dividend declaration or capital allocation plans following the approval of FY26 audited results?
What strategic expansions or pipeline developments is Gennex Laboratories planning for FY27 that could impact its financial outlook?

































